| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 50 |
| 1 | PREDNISONE | 21 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 20 |
| 3 | ACETAMINOPHEN | 19 |
| 4 | TREPROSTINIL | 18 |
| 5 | FUROSEMIDE | 16 |
| 6 | ACETAMINOPHEN 500MG | 15 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 15 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 15 |
| 9 | PAIN RELIEVER | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIMETHYL SULFOXIDE | 2 | 0.0082 |
| 1 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 2 | FOSCARBIDOPA/FOSLEVODOPA | 20 | 0.0023 |
| 3 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 4 | ADO-TRASTUZUMAB EMTANSINE | 7 | 0.0008 |
| 5 | SACITUZUMAB GOVITECAN | 4 | 0.0008 |
| 6 | ALGLUCOSIDASE ALFA | 2 | 0.0008 |
| 7 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 2 | 0.0008 |
| 8 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 2 | 0.0008 |
| 9 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 53 |
| 1 | Corticosteroid [EPC] | 40 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | Factor Xa Inhibitor [EPC] | 21 |
| 4 | Prostacycline Vasodilator [EPC] | 20 |
| 5 | Loop Diuretic [EPC] | 19 |
| 6 | Endothelin Receptor Antagonist [EPC] | 17 |
| 7 | beta-Adrenergic Blocker [EPC] | 13 |
| 8 | Aminosalicylate [EPC] | 12 |
| 9 | Provitamin D2 Compound [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Integrin Receptor Antagonist [EPC] | 53 | 0.0006 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 4 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 7 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 9 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 8 | 0.0003 |